BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ACMELAB

All Eps Dividend Board Agm Q1 Q2 Q3

ACMELAB 10-Oct-2017

The Board of Directors has recommended 35% cash dividend for the year ended on June 30, 2017. Date of AGM: 04.12.2017, Time: 10:30 AM, Venue: PSC Convention Hall, Mirpur-14 Dhaka-1206. Record Date: 31.10.2017. The Company has also reported EPS of Tk. 6.61, NAV per share of Tk. 80.13 and NOCFPS of Tk. 6.60 for the year ended on June 30, 2017 as against Tk. 6.55, Tk. 77.34 and Tk. 6.25 respectively for the same period of the previous year.

ACMELAB 03-Oct-2017

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 09, 2017 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.

ACMELAB 09-Jul-2017

(continuation news of ACMELAB): The ACME Laboratories Limited is the first certified Company of Orion Registrar Inc., USA that has successfully upgraded its existing ISO certification under 9001:2015 among the Pharmaceuticals Companies in Bangladesh. (end)

ACMELAB 09-Jul-2017

The Company has informed that they have received the certificate of up gradation of ISO Standard from 9001:2008 to 9001:2015 version after a thorough audit of all relevant departments of Plant, Head office and Depots by Orion Registrar, Inc., USA. As per certificate of certification used by the Orion Registrar Inc., USA, The Quality management System is applicable to Marketing, Human Resources and Supply Chain etc. of Human and Veterinary Pharmaceuticals Products of the Company. (cont.)

ACMELAB 30-Apr-2017

(Q3 Un-audited): EPS was Tk. 1.82 for January-March, 2017 as against Tk. 1.55 for January-March, 2016; EPS was Tk. 5.42 for July, 2016-March, 2017 as against Tk. 4.48 for July, 2015-March, 2016. NOCFPS was Tk. 5.18 for July, 2016-March, 2017 as against Tk. 6.31 for July, 2015-March, 2016. NAV per share was Tk. 79.27 as of March 31, 2017 and Tk. 77.34 as of June 30, 2016.

ACMELAB 25-Apr-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2017 at 10:00 AM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.

ACMELAB 29-Jan-2017

(Q2 Un-audited): EPS was Tk. 1.81 for October-December, 2016 as against Tk. 1.50 for October-December, 2015; EPS was Tk. 3.60 for July-December, 2016 as against Tk. 2.93 for July-December, 2015. NOCFPS was Tk. 4.01 for July-December, 2016 as against Tk. 3.16 for July-December, 2015. NAV per share was Tk. 77.43 as of December 31, 2016 and Tk. 77.34 as of June 30, 2016.

ACMELAB 24-Jan-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2017 at 12:00 Noon to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.

ACMELAB 12-Dec-2016

DSE NEWS: The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase any security of The ACME Laboratories Ltd. in between 1st to 30th trading day after change of categorization, starting from December 14, 2016 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.

ACMELAB 12-Dec-2016

The Company will be placed in 'A' category from existing 'N' category with effect from December 14, 2016 as the Company has reported disbursement of 35% cash dividend for the year ended on June 30, 2016.

Previous Next page